Silexion Therapeutics Corp (SLXN) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Silexion Therapeutics Corp (SLXN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Silexion Therapeutics Corp, the average estimate for 2030 earnings per share is −$1.60; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Silexion Therapeutics Corp (SLXN) forecast — frequently asked questions
What are analysts forecasting for Silexion Therapeutics Corp's earnings?
The average analyst estimate for Silexion Therapeutics Corp (SLXN) earnings per share in 2030 is -1.60, with individual estimates between -1.60 and -1.60.
How much revenue is Silexion Therapeutics Corp expected to make?
Analysts forecast Silexion Therapeutics Corp (SLXN) revenue of $34.99M in 2030, based on 1 published estimates.
How many analysts cover SLXN?
1 analyst contribute estimates for Silexion Therapeutics Corp (SLXN). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.